83
Views
3
CrossRef citations to date
0
Altmetric
Theme: General - Reviews

Elderly patients and intra-arterial stroke therapy

, , &
Pages 1713-1723 | Published online: 10 Jan 2014

References

  • Lloyd-Jones D, Adams RJ, Brown TM et al. Heart disease and stroke statistics – 2010 update: a report from the American Heart Association. Circulation 121(7), e46–e215 (2010).
  • Oskvig RM. Special problems in the elderly. Chest 115(5 Suppl.), 158S–164S (1999).
  • Mukherjee D, Patil CG. Epidemiology and the global burden of stroke. World Neurosurg. 76(6 Suppl.), S85–90 (2011).
  • Chandra RV, Leslie-Mazwi TM, Oh DC et al. Elderly patients are at higher risk for poor outcomes after intra-arterial therapy. Stroke 43(9), 2356–2361 (2012).
  • Rothwell PM, Coull AJ, Silver LE et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 366(9499), 1773–1783 (2005).
  • Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet 349(9064), 1498–1504 (1997).
  • Saposnik G, Black SE, Hakim A, Fang J, Tu JV, Kapral MK. Age disparities in stroke quality of care and delivery of health services. Stroke 40(10), 3328–3335 (2009).
  • Fonarow GC, Reeves MJ, Zhao X et al. Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation 121(7), 879–891 (2010).
  • Grady C. The cognitive neuroscience of ageing. Nat. Rev. Neurosci. 13(7), 491–505 (2012).
  • Kolb B, Teskey GC. Age, experience, injury, and the changing brain. Dev. Psychobiol. 54(3), 311–325 (2012).
  • Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 38(3), 967–973 (2007).
  • Saver JL, Albers GW, Dunn B, Johnston KC, Fisher M. Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. Stroke 40(7), 2594–2600 (2009).
  • Cloft HJ, Rabinstein A, Lanzino G, Kallmes DF. Intra-arterial stroke therapy: an assessment of demand and available work force. AJNR Am. J. Neuroradiol. 30(3), 453–458 (2009).
  • Hirsch JA, Yoo AJ, Nogueira RG et al. Case volumes of intra-arterial and intravenous treatment of ischemic stroke in the USA. J. Neurointerv. Surg. 1(1), 27–31 (2009).
  • Rost NS, Smith EE, Nogueira RG et al. Implementation of a patient selection protocol for intra-arterial therapy increases treatment rates in patients with acute ischemic stroke. J. Neurointerv. Surg. 5(Suppl. 1), i44–47 (2012).
  • Mehta B, Leslie-Mazwi TM, Chandra RV et al. Assessing variability in neurointerventional practice patterns for acute ischemic stroke. J. Neurointerv. Surg. 5(Suppl. 1), i52–57 (2012).
  • Abou-Chebl A. Endovascular treatment of acute ischemic stroke may be safely performed with no time window limit in appropriately selected patients. Stroke 41(9), 1996–2000 (2010).
  • Mishra NK, Albers GW, Davis SM et al. Mismatch-based delayed thrombolysis: a meta-analysis. Stroke 41(1), e25–33 (2010).
  • Kidwell CS, Jahan R, Gornbein J et al. A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke. N. Engl. J. Med. 368, 914–923, (2013).
  • Ciccone A, Valvassori L, Nichelatti M et al. Endovascular Treatment for Acute Ischemic Stroke. N. Engl. J. Med. 368, 904–913, (2013).
  • Broderick JP, Palesch YY, Demchuk AM et al. Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke. N. Engl. J. Med. 368, 893–903, (2013).
  • Rosamond W, Flegal K, Furie K et al. Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117(4), e25–146 (2008).
  • Fonarow GC, Smith EE, Saver JL et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation 123(7), 750–758 (2011).
  • Chen CI, Iguchi Y, Grotta JC et al. Intravenous TPA for very old stroke patients. Eur. Neurol. 54(3), 140–144 (2005).
  • Engelter ST, Reichhart M, Sekoranja L et al. Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology. 65(11), 1795–1798 (2005).
  • Toni D, Lorenzano S, Agnelli G et al. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy. Cerebrovasc. Dis. 25(1–2), 129–135 (2008).
  • Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N. Engl. J. Med. 333(24), 1581–1587 (1995).
  • Hacke W, Kaste M, Fieschi C et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274(13), 1017–1025 (1995).
  • Hacke W, Furlan AJ, Al-Rawi Y et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol. 8(2), 141–150 (2009).
  • Ford GA, Ahmed N, Azevedo E et al. Intravenous alteplase for stroke in those older than 80 years old. Stroke 41(11), 2568–2574 (2010).
  • Engelter ST, Bonati LH, Lyrer PA. Intravenous thrombolysis in stroke patients of > or = 80 versus < 80 years of age—a systematic review across cohort studies. Age Ageing. 35(6), 572–580 (2006).
  • Mishra NK, Ahmed N, Andersen G et al. Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive. BMJ 341, c6046 (2010).
  • Sandercock P, Wardlaw JM, Lindley RI et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 379(9834), 2352–2363 (2012).
  • The Interventional Management of Stroke (IMS) II study. Stroke 38(7), 2127–2135 (2007).
  • Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke. The proact II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 282(21), 2003–2011 (1999).
  • Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 40(8), 2761–2768 (2009).
  • Smith WS, Sung G, Saver J et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 39(4), 1205–1212 (2008).
  • Saver JL, Jahan R, Levy EI et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 380(9849), 1241–1249 (2012).
  • Nogueira RG, Lutsep HL, Gupta R et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 380(9849), 1231–1240 (2012).
  • Willey JZ, Ortega-Gutierrez S, Petersen N et al. Impact of acute ischemic stroke treatment in patients >80 years of age: the specialized program of translational research in acute stroke (SPOTRIAS) consortium experience. Stroke 43(9), 2369–2375 (2012).
  • Mono ML, Romagna L, Jung S et al. Intra-arterial thrombolysis for acute ischemic stroke in octogenarians. Cerebrovasc. Dis. 33(2), 116–122 (2012).
  • Ghobrial GM, Chalouhi N, Rivers L et al. Multimodal endovascular management of acute ischemic stroke in patients over 75 years old is safe and effective. J. Neurointerv. Surg. 5 (Suppl. 1), i33–37 (2013).
  • Mazighi M, Labreuche J, Meseguer E et al. Impact of a combined intravenous/intra-arterial approach in octogenarians. Cerebrovasc. Dis. 31(6), 559–565 (2011).
  • Loh Y, Kim D, Shi ZS et al. Higher rates of mortality but not morbidity follow intracranial mechanical thrombectomy in the elderly. AJNR Am. J. Neuroradiol. 31(7), 1181–1185 (2010).
  • Qureshi AI, Suri MF, Georgiadis AL, Vazquez G, Janjua NA. Intra-arterial recanalization techniques for patients 80 years or older with acute ischemic stroke: pooled analysis from 4 prospective studies. AJNR Am. J. Neuroradiol. 30(6), 1184–1189 (2009).
  • Pundik S, McWilliams-Dunnigan L, Blackham KL et al. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke. J. Stroke Cerebrovasc. Dis. 17(5), 266–272 (2008).
  • Kim D, Ford GA, Kidwell CS et al. Intra-arterial thrombolysis for acute stroke in patients 80 and older: a comparison of results in patients younger than 80 years. AJNR Am. J. Neuroradiol. 28(1), 159–163 (2007).
  • Ribo M, Flores A, Rubiera M et al. Difficult catheter access to the occluded vessel during endovascular treatment of acute ischemic stroke is associated with worse clinical outcome. J. Neurointerv. Surg. 5 (Suppl. 1), i70–73 (2013).
  • Ghobrial GM, Chalouhi N, Rivers L et al. Multimodal endovascular management of acute ischemic stroke in patients over 75 years old is safe and effective. J. Neurointerv. Surg. 5(Suppl. 1), i33–37 (2012).
  • Hacke W, Bluhmki E, Steiner T et al. Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set: post hoc analysis of ECASS I. Stroke 29(10), 2073–2075 (1998).
  • Duncan PW, Jorgensen HS, Wade DT. Outcome measures in acute stroke trials: a systematic review and some recommendations to improve practice. Stroke 31(6), 1429–1438 (2000).
  • Rowland K. The PLAN score predicted death and severe disability in patients with acute ischemic stroke. Ann. Intern. Med. 158(4), JC13 (2013).
  • Schonewille WJ, Wijman CA, Michel P et al. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol. 8(8), 724–730 (2009).
  • Sairanen T, Strbian D, Soinne L et al. Intravenous thrombolysis of basilar artery occlusion: predictors of recanalization and outcome. Stroke 42(8), 2175–2179 (2011).
  • Brandt T, von Kummer R, Muller-Kuppers M, Hacke W. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke 27(5), 875–881 (1996).
  • Ezaki Y, Tsutsumi K, Onizuka M et al. Retrospective analysis of neurological outcome after intra-arterial thrombolysis in basilar artery occlusion. Surg. Neurol. 60(5), 423–429, discussion 429-430 (2003).
  • Vergouwen MD, Compter A, Tanne D et al. Outcomes of basilar artery occlusion in patients aged 75 years or older in the Basilar Artery International Cooperation Study. J. Neurol. 259(11), 2341–2346 (2012).
  • Sanossian N, Ovbiagele B. Prevention and management of stroke in very elderly patients. Lancet Neurol. 8(11), 1031–1041 (2009).
  • Wang HE, Mann NC, Jacobson KE et al. National characteristics of emergency medical services responses in the United States. Prehosp. Emerg. Care 17(1), 8–14 (2013).
  • Williams D, Bennett K, Feely J. Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care. Br. J. Clin. Pharmacol. 55(6), 604–608 (2003).
  • Khatri P, Abruzzo T, Yeatts SD, Nichols C, Broderick JP, Tomsick TA. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 73(13), 1066–1072 (2009).
  • Denti L, Scoditti U, Tonelli C et al. The poor outcome of ischemic stroke in very old people: a cohort study of its determinants. J. Am. Geriatr. Soc. 58(1), 12–17 (2010).
  • Di Carlo A, Lamassa M, Pracucci G et al. Stroke in the very old : clinical presentation and determinants of 3-month functional outcome: a European perspective. European BIOMED study of stroke care group. Stroke 30(11), 2313–2319 (1999).
  • Priebe HJ. The aged cardiovascular risk patient. Br. J. Anaesth. 85(5), 763–778 (2000).
  • Abou-Chebl A, Lin R, Hussain MS et al. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: preliminary results from a retrospective, multicenter study. Stroke 41(6), 1175–1179 (2010).
  • Davis MJ, Menon BK, Baghirzada LB et al. Anesthetic management and outcome in patients during endovascular therapy for acute stroke. Anesthesiology 116(2), 396–405 (2012).
  • Ribo M, Flores A, Rubiera M et al. Difficult catheter access to the occluded vessel during endovascular treatment of acute ischemic stroke is associated with worse clinical outcome. J. Neurointerv. Surg. 5(Suppl. 1), i70–73 (2012).
  • Tummala RP, Jahromi BS, Yamamoto J, Levy EI, Siddiqui AH, Hopkins LN. Carotid artery stenting under flow arrest for the management of intraluminal thrombus: technical case report. Neurosurgery 63(1 Suppl. 1), ONSE87-88, discussion ONSE88 (2008).
  • Tandberg Askevold E, Naess H, Thomassen L. Predictors for recanalization after intravenous thrombolysis in acute ischemic stroke. J. Stroke Cerebrovasc. Dis. 16(1), 21–24 (2007).
  • Ikarugi H, Yamashita T, Aoki R, Ishii H, Kanki K, Yamamoto J. Impaired spontaneous thrombolytic activity in elderly and in habitual smokers, as measured by a new global thrombosis test. Blood Coagul. Fibrinolysis. 14(8), 781–784 (2003).
  • Yamashita T, Sato A, Ikarugi H et al. Significantly reduced spontaneous thrombolytic activity in older men: a possible explanation for the gender differences in risk of acute coronary syndromes. Thromb. Res. 116(2), 127–131 (2005).
  • Saposnik G, Kapral MK, Coutts SB, Fang J, Demchuk AM, Hill MD. Do all age groups benefit from organized inpatient stroke care? Stroke 40(10), 3321–3327 (2009).
  • Derex L, Nighoghossian N. Thrombolysis, stroke-unit admission and early rehabilitation in elderly patients. Nat. Rev. Neurol. 5(9), 506–511 (2009).
  • Samsa GP, Matchar DB, Goldstein L et al. Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke. Am. Heart J. 136(4 Pt 1), 703–713 (1998).
  • Beach MC, Morrison RS. The effect of do-not-resuscitate orders on physician decision-making. J. Am. Geriatr. Soc. 50(12), 2057–2061 (2002).
  • Hemphill JC 3rd, Newman J, Zhao S, Johnston SC. Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke 35(5), 1130–1134 (2004).
  • Zahuranec DB, Brown DL, Lisabeth LD et al. Early care limitations independently predict mortality after intracerebral hemorrhage. Neurology 68(20), 1651–1657 (2007).
  • Mayer SA, Kossoff SB. Withdrawal of life support in the neurological intensive care unit. Neurology 52(8), 1602–1609 (1999).
  • Ford AB, Roy AW, Haug MR, Folmar SJ, Jones PK. Impaired and disabled elderly in the community. Am. J. Public Health 81(9), 1207–1209 (1991).
  • Falconer JA, Naughton BJ, Strasser DC, Sinacore JM. Stroke inpatient rehabilitation: a comparison across age groups. J. Am. Geriatr. Soc. 42(1), 39–44 (1994).
  • Holloway RG, Benesch CG, Burgin WS, Zentner JB. Prognosis and decision making in severe stroke. JAMA 294(6), 725–733 (2005).
  • Fields JD, Khatri P, Nesbit GM et al. Meta-analysis of randomized intra-arterial thrombolytic trials for the treatment of acute stroke due to middle cerebral artery occlusion. J. NeuroInterv. Surg. 3(2), 151–155 (2011).
  • Ogawa A, Mori E, Minematsu K et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 38(10), 2633–2639 (2007).
  • Demchuk AM, IMS III Investigators. IMS III: Comparison of Outcomes between IV and IV/IA Treatment in Baseline CTA Confirmed ICA, M1, M2 and Basilar Occlusions. In: International Stroke Conference.Honolulu, Hawaii, 6–8 February 2013.
  • Williams MA, Fleg JL, Ades PA et al. Secondary prevention of coronary heart disease in the elderly (with emphasis on patients > or =75 years of age): an American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation 105(14), 1735–1743 (2002).
  • Flint AC, Cullen SP, Faigeles BS, Rao VA. Predicting long-term outcome after endovascular stroke treatment: the totaled health risks in vascular events score. AJNR Am. J. Neuroradiol. 31(7), 1192–1196 (2010).
  • Yoo AJ, Chaudhry ZA, Nogueira RG et al. Infarct volume is a pivotal biomarker after intra-arterial stroke therapy. Stroke 43(5), 1323–1330 (2012).
  • Hannan EL, Magaziner J, Wang JJ et al. Mortality and locomotion 6 months after hospitalization for hip fracture: risk factors and risk-adjusted hospital outcomes. JAMA 285(21), 2736–2742 (2001).
  • Kasner SE. Clinical interpretation and use of stroke scales. Lancet Neurol. 5(7), 603–612 (2006).
  • Saver JL, Gornbein J. Treatment effects for which shift or binary analyses are advantageous in acute stroke trials. Neurology 72(15), 1310–1315 (2009).
  • Ciccone A, Valvassori L, Gasparotti R, Scomazzoni F, Ballabio E, Sterzi R. Debunking 7 myths that hamper the realization of randomized controlled trials on intra-arterial thrombolysis for acute ischemic stroke. Stroke 38(7), 2191–2195 (2007).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.